Pilot Placebo Controlled Study With Lovaza in Cardiovascular Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

March 31, 2010

Study Completion Date

June 30, 2010

Conditions
HIV InfectionsHeart Disease
Interventions
DRUG

Lovaza

Lovaza one gram twice a day for 24 weeks

DRUG

Placebo

Placebo

Trial Locations (1)

44106

University Hospitals of Cleveland Case Medical Center, Cleveland

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

The Campbell Foundation

OTHER

collaborator

Case Western Reserve University

OTHER

collaborator

GlaxoSmithKline

INDUSTRY

lead

University Hospitals Cleveland Medical Center

OTHER